Albis Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Lightpharmtech Co., Ltd.
MFDS item code 201901862 · Approved 2019.03.28
This product's status changed to Expired on 2024.03.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal diseases such as gastric and duodenal ulcers, gastritis.
This medication is used for various gastrointestinal diseases including gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia and helps prevent ulcers post-surgery. It is used for the treatment of gastric and duodenal ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs). This medication effectively aids in improving a range of gastrointestinal conditions.
For adults, typically take 2 tablets orally, twice a day, in the morning and before bed, regardless of meals. For gastric and duodenal ulcers, take 2 tablets twice a day or 4 tablets once at bedtime; for patients with duodenal ulcers, 4 tablets can be taken twice a day in the morning and before bed. The same dosage applies for ulcers resulting from NSAID administration or long-term use. Recurrent ulcer patients who showed excellent results from short-term therapy should take 2 tablets once a day at bedtime as maintenance therapy.
This medication should not be used by patients undergoing dialysis. Individuals who have had allergic reactions to this drug or any of its components should not use it. Patients with a history of a rare disease called acute porphyria should not be administered this drug as it may worsen symptoms. Patients with impaired kidney function or kidney disorders should not use this drug. Patients who have undergone upper gastrointestinal surgery should preferably avoid taking this drug. Women who are pregnant or may become pregnant should not take this drug. It has not been established as safe for premature infants or newborns, so it is not administered to them. Patients on dietary restrictions that limit potassium intake should not use this drug. Patients with liver dysfunction should use this drug cautiously, and those with a history of drug allergies should also exercise caution. Elderly patients or those with a history of kidney disorders should also be careful when using this drug. If taken in conjunction with NSAIDs, particularly in the elderly or those with a history of peptic ulcers, it is important to have regular check-ups. This medication may mask symptoms of gastric cancer, so gastric ulcer patients or middle-aged patients with newly developed dyspeptic symptoms should confirm they do not have a malignant condition before using it. Patients with gastric or duodenal ulcers caused by Helicobacter pylori infection should receive simultaneous treatment to eradicate the bacteria. In severely ill patients in intensive care, there may be a risk of developing a gastric stone, so caution is advised. Patients with hypophosphatemia should be aware that the components of this medication may interfere with phosphate absorption. Patients with swallowing difficulties have reported respiratory complications after administration of this drug, so they should be cautious. During treatment with this drug, there is a rare possibility of experiencing allergic reactions or shock; if symptoms occur, treatment should be stopped immediately and medical attention sought. Blood tests may reveal abnormalities like leukopenia or thrombocytopenia. If there are changes in physical condition, immediate testing is advised. Liver function abnormalities may occur, so if symptoms of hepatitis or jaundice appear, medication should be discontinued immediately. Circulatory system abnormalities such as arrhythmias or vasculitis may occur rarely, so vigilance is needed. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain. CNS symptoms such as dizziness, drowsiness, confusion, seizures, and insomnia may occur rarely, so if unusual symptoms appear, consultation with a healthcare provider is necessary. Myalgia or arthralgia, and in rare cases symptoms of muscle damage may occur, so treatment should be stopped if symptoms are severe. Dermatological reactions, such as skin rash or hair loss, have also been reported rarely. It is important to avoid long-term use, and during treatment, regular monitoring of blood, liver, and kidney function is crucial. If dizziness or drowsiness occurs while taking this medication, driving and operating dangerous machinery should be avoided. There may be interactions with other medications, so it is essential to inform your healthcare provider of any other drugs being taken. Women who are pregnant or breastfeeding should not take this medication, and its safety for children has not been established, so its use is not recommended. In case of overdose, emergency treatments like vomiting or gastric lavage may be necessary, so caution is advised.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, shock, anaphylaxis, angioedema, severe allergic reactions, elevated serum enzyme levels, hepatitis (both jaundice and non-jaundice types), liver dysfunction, tachycardia, bradycardia, atrioventricular block, arrhythmia, vasculitis, seizures, altered consciousness, convulsions, myoclonus, rhabdomyolysis, agranulocytosis, pancytopenia, aplastic anemia, acquired immune hemolytic anemia, and acute seizure.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure and kept at room temperature between 1°C and 30°C. Storing it this way will help maintain its efficacy for a longer period.
Green round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Lightpharmtech Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.